PPARGC1A and breast carcinoma: Our analysis did not show significant changes in PGC1α expression in metastatic vs primary cancers, suggesting that the findings of LeBleu are not a common feature of the metabolic transformation of cancer but, likely, apply to a specific subset of breast cancers.